The latest report by IMARC Group, titled “Cell Dissociation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global cell dissociation market size reached US$ 314.84 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 716.92 Million by 2028, exhibiting a growth rate (CAGR) of 14.10% during 2023-2028.

Cell dissociation refers to the process of detaching cells from each other and their extracellular matrix, enabling their isolation and manipulation for various scientific and medical purposes. This crucial procedure is extensively employed in biotechnology, pharmaceutical research, and clinical applications, facilitating cell culture maintenance, cell counting, and cell-based assays. Through the use of enzymatic or mechanical methods, cell dissociation ensures the extraction of individual cells from tissue samples or cell cultures while preserving their viability and functional integrity. This process is pivotal in numerous fields, including regenerative medicine, drug discovery, and tissue engineering. As a result, cell dissociation plays a fundamental role in advancing research and applications that rely on cell-based technologies.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cell-dissociation-market/requestsample

Cell Dissociation Market Trends and Drivers:

The global cell dissociation market is primarily driven by the escalating demand for efficient cell isolation techniques in the biopharmaceutical and biotechnology sectors. Moreover, the heightened focus on developing advanced cell therapies and regenerative medicine solutions has catalyzed the demand for sophisticated cell dissociation tools and reagents, fostering market growth worldwide. Additionally, the prevalence of chronic diseases and the rising need for personalized medicine have accelerated the adoption of cell dissociation techniques in the development of targeted therapies and precision medicine approaches. Furthermore, ongoing advancements in tissue engineering and organ transplantation research have spurred the demand for precise and reliable cell dissociation methodologies. This, in turn, is creating lucrative opportunities for key players to introduce innovative products and solutions catering to the evolving needs of the biomedical research community, thereby propelling market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Product Insights:

• Enzymatic Dissociation
  • Trypsin
  • Collagenase
  • Elastase
  • Papain
  • Hyaluronidase
  • DNase
  • Others
• Non-Enzymatic Dissociation
• Instruments and Accessories

Type Insights:

• Tissue Dissociation
• Cell Detachment

End Use Insights:

• Pharmaceutical and Biotechnology Companies
• Research and Academic Institutes

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• Becton Dickinson and Company
• Capricorn Scientific GmbH
• Cytiva (Danaher Corporation)
• F. Hoffmann-La Roche Ltd.
• HiMedia Laboratories Pvt. Ltd.
• Miltenyi Biotec
• PAN-Biotech GmbH
• Sartorius AG
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.
• Vitacyte LLC

Explore full report with table of contents: https://www.imarcgroup.com/cell-dissociation-market

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA 

Follow us on Twitter: @imarcglobal